← Back to headlines
Medpace Holdings (MEDP) Benefits from GLP-1 Drug Market Strength
Medpace Holdings (MEDP) has reportedly seen benefits from the strong performance and demand within the GLP-1 drug market.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
